Post

New research · Ophthalmology
Eye (London, England) · 13h
Cohort studyEye (London, England) · 2026

Clinical outcomes of weekly adalimumab in refractory non-infectious paediatric uveitis and the role of serum drug levels and anti-adalimumab antibodies.

Amelia Rees, Raheej Khan, Jessy Choi … Jane Ashworth
Read paper
OphthalmologyCohort study

Weekly adalimumab controlled refractory paediatric uveitis in two-thirds of patients.

Clinical outcomes of weekly adalimumab in refractory non-infectious paediatric uveitis and the role of serum drug levels and anti-adalimumab antibodies.

Amelia Rees … Jane Ashworth
Eye (London, England) · 2026
Background

Adalimumab (adalimumab) is a well-established treatment for refractory paediatric uveitis; however, some patients remain inadequately controlled on standard biweekly dosing.

Purpose

This study evaluates outcomes of escalation to weekly adalimumab in children with refractory uveitis and explores the relevance of serum drug levels and anti-adalimumab antibodies (anti-ADA antibodies).

Methods

With idiopathic uveitis at two tertiary centres in the UK treated with weekly adalimumab were retrospectively reviewed.

n = 15 patients
Results

adalimumab controlled eye inflammation in two-thirds of children

Pre-escalation
47%
Post-escalation
13.3%
More results

Mean age at escalation was 11 years (range: 3-17).

11 (73%) had a systemic diagnosis; most commonly juvenile idiopathic arthritis (60%).

Median serum level pre-escalation was 10.1 mg/L (IQR: 7.8-11.9) and 18.1 mg/L (IQR: 14.8-22.1) post escalation.

More results

AAAs were detectable in 7/15 (47%) pre-escalation, 2/15 (13.3%) post-escalation.

“
Conclusion · 1 of 2

Weekly adalimumab offers a safe and effective treatment alternative for children with refractory uveitis, including those with AAAs.

Conclusion · 2 of 2

These findings support its inclusion in future treatment pathways, though the predictive value of serum levels and AAAs remains uncertain and warrants further investigation.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment